Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 93551-93600 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT04907565
Impact of Obesity on Post-operative Cognitive Dysfunction: Role of Adipose Tissue
N/ARecruiting
408 participants
Started: Sep 21, 2021 · Completed: Sep 21, 2025
3 conditions1 sponsor1 location
NCT04710628
Combination of Pembrolizumab and Lenvatinib, in Pre-treated Thymic CArcinoma paTIents
PHASE2Active, not recruiting
43 participants
Started: Sep 21, 2021 · Completed: Jan 31, 2026
2 conditions2 sponsors13 locations
NCT04897334
Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke
NARecruiting
70 participants
Started: Sep 21, 2021 · Completed: Jan 31, 2027
2 conditions1 sponsor1 location
NCT05836610
Hydrocortisone Therapy Optimization During Hypothermia Treatment in Asphyxiated Neonates
PHASE4Recruiting
50 participants
Started: Sep 21, 2021 · Completed: Sep 30, 2027
4 conditions1 sponsor1 location
NCT06103851
Effect of Mask Use on Jaw Functionality
N/AActive, not recruiting
24 participants
Started: Sep 21, 2021 · Completed: Nov 30, 2023
1 condition1 sponsor1 location
NCT04852653
A Prospective Feasibility Study Evaluating Extracellular Vesicles Obtained by Liquid Biopsy for Neoadjuvant Treatment Response Assessment in Rectal Cancer
N/AActive, not recruiting
58 participants
Started: Sep 21, 2021 · Completed: Mar 31, 2026
2 conditions1 sponsor1 location
NCT04953104
ARID1A and/or KDM6A Mutation and CXCL13 Expression
PHASE2Active, not recruiting
6 participants
Started: Sep 21, 2021 · Completed: Dec 31, 2026
32 conditions1 sponsor1 location
NCT04752592
Evaluation of a Rapid Point-of-Care Serological Triage Test for Active TB
NAActive, not recruiting
9,097 participants
Started: Sep 21, 2021 · Completed: Dec 31, 2025
1 condition10 sponsors3 locations
NCT04965493
A Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus Venetoclax and Rituximab (VR) in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
PHASE3Active, not recruiting
600 participants
Started: Sep 20, 2021 · Completed: Jan 31, 2027
2 conditions2 sponsors176 locations
NCT04261127
Validation of the RADIAL Algorithm for Diagnosis of Autosomal Recessive Cerebellar Ataxia
NARecruiting
400 participants
Started: Sep 20, 2021 · Completed: Sep 30, 2029
1 condition1 sponsor8 locations
NCT04786977
Physiologic Measure of VIPN
N/ARecruiting
40 participants
Started: Sep 20, 2021 · Completed: Dec 1, 2025
1 condition1 sponsor1 location
NCT05017649
Role of A2A Receptor in Hypercholesterolemic Patients
NARecruiting
150 participants
Started: Sep 20, 2021 · Completed: Jun 19, 2026
1 condition1 sponsor1 location
NCT05064540
JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization
NARecruiting
450 participants
Started: Sep 20, 2021 · Completed: Mar 31, 2031
2 conditions1 sponsor29 locations
NCT06087367
Building of a Diagnostic/Prognostic Database for Human ERG Variant Effects
N/ARecruiting
600 participants
Started: Sep 20, 2021 · Completed: Mar 24, 2026
1 condition3 sponsors2 locations
NCT06192446
Factors Influencing Adherence to Adjuvant Endocrine Therapy
N/ARecruiting
1,000 participants
Started: Sep 20, 2021 · Completed: Sep 20, 2024
1 condition1 sponsor1 location
NCT04594798
A Study of Polatuzumab Vedotin, Rituximab and Dose Attenuated CHP in Older Patients with DLBCL
PHASE2Recruiting
39 participants
Started: Sep 20, 2021 · Completed: Jul 31, 2026
2 conditions2 sponsors1 location
NCT05014399
Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy
N/ARecruiting
60 participants
Started: Sep 20, 2021 · Completed: Oct 31, 2031
8 conditions2 sponsors1 location
NCT05106140
Robotic Evaluations of Motor Learning During Stroke Neurorehabilitation
N/ARecruiting
300 participants
Started: Sep 20, 2021 · Completed: Sep 1, 2026
1 condition2 sponsors4 locations
NCT06025903
Assessing the Role of Mitochondrial Dysfunction in Primary Progressive Multiple Sclerosis
N/ARecruiting
140 participants
Started: Sep 20, 2021 · Completed: May 30, 2025
1 condition2 sponsors2 locations
NCT05090878
Atherogenic Lipoproteins in Ischemic Stroke
N/ARecruiting
500 participants
Started: Sep 20, 2021 · Completed: Dec 31, 2025
1 condition2 sponsors2 locations
NCT05077280
A Study of Concurrent Stereotactic Body Radiotherapy With Opdualag in Metastatic Uveal Melanoma
PHASE2Recruiting
40 participants
Started: Sep 20, 2021 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT05039229
Measures for Bioaerosol Reduction in the Salmon Industry
NAEnrolling by invitation
2,000 participants
Started: Sep 20, 2021 · Completed: Apr 30, 2025
2 conditions6 sponsors1 location
NCT04578249
Effects of Blocking Blue Light At Night Post CABG, AVR, MVR, CABG AVR, CABG MVR, or SAH
NARecruiting
80 participants
Started: Sep 20, 2021 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT05047731
Antihypertensive Deprescribing in Long-term Care
NAActive, not recruiting
450 participants
Started: Sep 20, 2021 · Completed: Jun 30, 2025
2 conditions2 sponsors1 location
NCT04784494
MST for Parkinson's Disease
NAActive, not recruiting
20 participants
Started: Sep 20, 2021 · Completed: Feb 28, 2025
4 conditions1 sponsor1 location
NCT04978636
Low Tidal Volume Ventilation With Hyperoxia Avoidance During Cardiopulmonary Bypass (The FOCUS Trial)
NARecruiting
5,502 participants
Started: Sep 20, 2021 · Completed: Mar 30, 2027
1 condition4 sponsors1 location
NCT04726319
Family History App in Personalized Medicine
NAActive, not recruiting
627 participants
Started: Sep 20, 2021 · Completed: Dec 31, 2025
7 conditions1 sponsor1 location
NCT05108558
Efficacy of a Novel CCH Protocol for PD Among Prior Non-responders
PHASE4Active, not recruiting
40 participants
Started: Sep 20, 2021 · Completed: Sep 20, 2028
1 condition1 sponsor1 location
NCT04681872
Marshall Ethanolization, Pulmonary Vein Isolation and Line Completion for Ablation of Persistent Atrial Fibrillation
NAActive, not recruiting
262 participants
Started: Sep 20, 2021 · Completed: Sep 20, 2027
1 condition1 sponsor9 locations
NCT04826341
A Phase I/II Study of Sacituzumab Govitecan Plus Berzosertib in Small Cell Lung Cancer, Extra-Pulmonary Small Cell Neuroendocrine Cancer and Homologous Recombination-Deficient Cancers Resistant to PARP Inhibitors
PHASE1/PHASE2Recruiting
120 participants
Started: Sep 20, 2021 · Completed: Mar 1, 2027
3 conditions1 sponsor1 location
NCT04313114
The PRIME-CRC Trial to Promote CRC Screening in Rural Communities
NAActive, not recruiting
804 participants
Started: Sep 20, 2021 · Completed: May 31, 2026
1 condition3 sponsors3 locations
NCT04859088
Biologics and Partial Enteral Nutrition Study
NARecruiting
80 participants
Started: Sep 20, 2021 · Completed: Sep 30, 2026
1 condition2 sponsors4 locations
NCT05047913
Comprehensive Evaluation of Tumor Oxygenation, Metabolism and Blood Supply of High Grade Glioma and Cervical Cancers Using Dynamic FAZA PET and Multiparametric MR
EARLY_PHASE1Active, not recruiting
20 participants
Started: Sep 20, 2021 · Completed: Feb 2, 2027
2 conditions1 sponsor1 location
NCT04793412
Cochlear Implantation in Children With Asymmetric Hearing Loss or Single-Sided Deafness Clinical Trial
NARecruiting
80 participants
Started: Sep 20, 2021 · Completed: Aug 31, 2026
3 conditions6 sponsors5 locations
NCT04896606
SARS-CoV-2 CTLS for Mild to Moderate COVID-19 Disease
PHASE1/PHASE2Recruiting
50 participants
Started: Sep 20, 2021 · Completed: Dec 31, 2025
1 condition4 sponsors4 locations
NCT04936464
Transcutaneous Tibial Nerve Stimulation for Urgency Urinary Incontinence
NAActive, not recruiting
99 participants
Started: Sep 20, 2021 · Completed: Jun 30, 2024
2 conditions2 sponsors1 location
NCT05095207
Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer
PHASE1/PHASE2Recruiting
42 participants
Started: Sep 20, 2021 · Completed: Dec 31, 2027
2 conditions1 sponsor3 locations
NCT04981795
realMIND: Observational Study on Safety and Effectiveness of Tafasitamab in Combination With Lenalidomide in Patients With Relapsed or Refractory DLBCL
N/ARecruiting
100 participants
Started: Sep 20, 2021 · Completed: Aug 31, 2026
1 condition1 sponsor25 locations
NCT06908369
Cardiac Symptoms in Patients With Treated Graves' Disease
N/AActive, not recruiting
75 participants
Started: Sep 20, 2021 · Completed: Oct 15, 2025
3 conditions1 sponsor1 location
NCT04957537
Semantic Rehabilitation for Patients With Primary Progressive Semantic Aphasia
NARecruiting
15 participants
Started: Sep 20, 2021 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT05059379
Medial vs. Entire Supraclavicular Lymph Node Radiation Therapy for Patients With Invasive Breast Cancer
PHASE3Recruiting
1,650 participants
Started: Sep 20, 2021 · Completed: Aug 31, 2027
3 conditions6 sponsors1 location
NCT04804098
Effect of Rate (Slope) of Compression on the Incidence of Symptomatic ETD and MEB: a Phase III Prospective Study.
NARecruiting
300 participants
Started: Sep 20, 2021 · Completed: Dec 1, 2024
7 conditions1 sponsor1 location
NCT05053230
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
NARecruiting
480 participants
Started: Sep 20, 2021 · Completed: Sep 20, 2026
8 conditions1 sponsor7 locations
NCT04837547
PEACH TRIAL- Precision Medicine and Adoptive Cellular Therapy
PHASE1Recruiting
24 participants
Started: Sep 20, 2021 · Completed: Sep 30, 2032
2 conditions2 sponsors3 locations
NCT04230694
Continuous Glucose Monitoring of Hospitalized Patients With Diabetes
NAActive, not recruiting
40 participants
Started: Sep 20, 2021 · Completed: Dec 31, 2024
4 conditions1 sponsor1 location
NCT04557462
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
PHASE3Recruiting
540 participants
Started: Sep 20, 2021 · Completed: Nov 11, 2032
1 condition1 sponsor146 locations
NCT04683718
A First in Human Feasibility Study to Evaluate the Safety and Effectiveness of the BIOTRONIK Prospera SCS System with HomeStream Remote Management
NAActive, not recruiting
60 participants
Started: Sep 20, 2021 · Completed: Jan 31, 2027
2 conditions3 sponsors5 locations
NCT04797286
Sildenafil for Early Pulmonary Vascular Disease in Scleroderma
PHASE2Recruiting
30 participants
Started: Sep 20, 2021 · Completed: Sep 1, 2026
2 conditions3 sponsors2 locations
NCT05078528
Low-cost Imaging Technology for Global Prevention of Cervical Cancer
NARecruiting
1,060 participants
Started: Sep 20, 2021 · Completed: Dec 3, 2025
1 condition4 sponsors2 locations
NCT04779216
Effects of Romosozumab on Bone Density in Women with Anorexia Nervosa
PHASE3Active, not recruiting
30 participants
Started: Sep 20, 2021 · Completed: Oct 31, 2025
4 conditions2 sponsors1 location